NERV Minerva: Earnings per share for the trailing year

Official company branding of Minerva Neurosciences Corp (NERV)

The annual percentage change in earnings per share (ttm) for Minerva Neurosciences (NERV) reflects pressure stemming from FDA restrictions on roluperidone and capital outflows. The current level is -1305.30. Minerva Neurosciences (NERV) is automating drug formula discovery via bioinformatics to reduce routine labor. Additionally, Minerva Neurosciences (NERV) is innovating therapies for sleep disorders and schizophrenia, developing molecules aimed at the social rehabilitation of patients.

Minerva Neurosciences (NERV) - Net earnings per share (EPS TTM) from 02/11/2024 to 11/14/2026

NERV (Minerva Neurosciences, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price Minerva Neurosciences Inc|NERV - Price Target Chart
- company stock capitalization data:
Market Value Minerva Neurosciences|NERV - Real Price to Acquire Entire Company
- issuer book value statistics:
Net Assets per Single Share Minerva Neurosciences|NERV - Book Capitalization|Market Capitalization to Book Value Ratio minervaneurosciences.com|NERV - Cumulative Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Minerva Neurosciences|NERV - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Minerva Neurosciences|NERV - Company Aggregate Debts|Debts to Book Value Minerva Neurosciences|NERV - Company Long-Term Liabilities|Company Short-Term Debts Minerva Neurosciences|Intermediate Coverage Ratio minervaneurosciences.com
- earnings and valuation multiples indicators:
NERV - Company Net Income|Expected Net Profit Minerva Neurosciences|NERV - Price to Earnings Ratio|Market Cap to Projected Earnings Minerva Neurosciences Corp|NERV - PEG Multiple|Enterprise Value to EBITDA Ratio Minerva Neurosciences Corp|NERV - Operating profit EBITDA|Net earnings per share for the last four quarters Minerva Neurosciences|NERV - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months minervaneurosciences.com|NERV - Earnings per share growth in current year|Projected earnings per share growth rate for next year Minerva Neurosciences
- sales and revenue indicators:
NERV - Revenue and Sales Volume|Company Future Sales Volume Minerva Neurosciences, Inc.|NERV - P/S Multiple|Market Cap to Future Revenue Ratio Minerva
Fundamental company valuation:NERV, Minerva Neurosciences Corp
Product sample of minervaneurosciences.com

This indicator measures the rolling dynamics of earnings per share (EPS) over a twelve-month period, neutralizing short-term quarterly fluctuations and identifying sustainable profitability trends. Analyzing the EPS YoY TTM shift allows for an assessment of how effectively Minerva Neurosciences (NERV) capitalizes on its innovative neurobiology developments and their subsequent impact on the company's financial results.

Direct competitors

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. HSDT|PASG: Net earnings per share (EPS TTM)|Neuphoria (NEUP) - Net earnings per share (EPS TTM)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE